Further, LKB1 inactivation induces a redox imbalance to promote transdifferentiation from lung adenocarcinoma to lung squamous cell carcinoma in NSCLC, which leads resistance to anti-tumor therapy [90]. This evidence concerns the gene STK11 and neoplasm.